Reported Earnings • 7h
Full year 2026 earnings released: EPS: ₹29.14 (vs ₹14.00 in FY 2025) Full year 2026 results: EPS: ₹29.14 (up from ₹14.00 in FY 2025). Revenue: ₹24.2b (up 78% from FY 2025). Net income: ₹1.80b (up 108% from FY 2025). Profit margin: 7.5% (up from 6.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. 공시 • May 27
Krishana Phoschem Limited, Annual General Meeting, Jun 24, 2026 Krishana Phoschem Limited, Annual General Meeting, Jun 24, 2026, at 12:30 Indian Standard Time. Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹702, the stock trades at a trailing P/E ratio of 24.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 213% over the past three years. New Risk • Apr 10
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (49% accrual ratio). Reported Earnings • Apr 10
Full year 2026 earnings released: EPS: ₹29.14 (vs ₹14.00 in FY 2025) Full year 2026 results: EPS: ₹29.14 (up from ₹14.00 in FY 2025). Revenue: ₹24.3b (up 79% from FY 2025). Net income: ₹1.80b (up 108% from FY 2025). Profit margin: 7.4% (up from 6.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. 공시 • Apr 07
Krishana Phoschem Limited to Report Q4, 2026 Results on Apr 08, 2026 Krishana Phoschem Limited announced that they will report Q4, 2026 results on Apr 08, 2026 Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹554, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 128% over the past three years. Reported Earnings • Jan 14
Third quarter 2026 earnings released: EPS: ₹5.39 (vs ₹3.32 in 3Q 2025) Third quarter 2026 results: EPS: ₹5.39 (up from ₹3.32 in 3Q 2025). Revenue: ₹6.59b (up 117% from 3Q 2025). Net income: ₹333.2m (up 62% from 3Q 2025). Profit margin: 5.1% (down from 6.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth. 공시 • Jan 07
Krishana Phoschem Limited to Report Q3, 2026 Results on Jan 12, 2026 Krishana Phoschem Limited announced that they will report Q3, 2026 results at 9:08 AM, Indian Standard Time on Jan 12, 2026 Reported Earnings • Oct 15
Second quarter 2026 earnings released: EPS: ₹5.36 (vs ₹2.71 in 2Q 2025) Second quarter 2026 results: EPS: ₹5.36 (up from ₹2.71 in 2Q 2025). Revenue: ₹6.08b (up 102% from 2Q 2025). Net income: ₹331.7m (up 98% from 2Q 2025). Profit margin: 5.5% (down from 5.6% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 49% per year. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹451, the stock trades at a trailing P/E ratio of 27.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 153% over the past three years. Upcoming Dividend • Aug 19
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 26 August 2025. Payment date: 02 October 2025. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%). 공시 • Aug 06
Krishana Phoschem Limited, Annual General Meeting, Sep 02, 2025 Krishana Phoschem Limited, Annual General Meeting, Sep 02, 2025, at 16:30 Indian Standard Time. New Risk • Aug 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.1% average weekly change). Minor Risk High level of debt (91% net debt to equity). Board Change • Aug 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Non–Executive Independent Director Shruti Babel was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 19
First quarter 2026 earnings released: EPS: ₹4.95 (vs ₹2.65 in 1Q 2025) First quarter 2026 results: EPS: ₹4.95 (up from ₹2.65 in 1Q 2025). Revenue: ₹3.96b (up 41% from 1Q 2025). Net income: ₹305.8m (up 86% from 1Q 2025). Profit margin: 7.7% (up from 5.8% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has increased by 55% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹417, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 216% over the past three years. New Risk • Jul 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (91% net debt to equity). Share price has been volatile over the past 3 months (7.5% average weekly change). Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹445, the stock trades at a trailing P/E ratio of 31.8x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 185% over the past three years. Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹363, the stock trades at a trailing P/E ratio of 25.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 108% over the past three years. Reported Earnings • May 08
Full year 2025 earnings released: EPS: ₹14.00 (vs ₹6.54 in FY 2024) Full year 2025 results: EPS: ₹14.00 (up from ₹6.54 in FY 2024). Revenue: ₹13.7b (up 48% from FY 2024). Net income: ₹865.4m (up 114% from FY 2024). Profit margin: 6.3% (up from 4.4% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 28% per year. Reported Earnings • Jan 16
Third quarter 2025 earnings released: EPS: ₹3.32 (vs ₹0.60 in 3Q 2024) Third quarter 2025 results: EPS: ₹3.32 (up from ₹0.60 in 3Q 2024). Revenue: ₹3.06b (up 33% from 3Q 2024). Net income: ₹205.3m (up 454% from 3Q 2024). Profit margin: 6.7% (up from 1.6% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. 공시 • Jan 15
Krishana Phoschem Limited to Report Q3, 2025 Results on Jan 15, 2025 Krishana Phoschem Limited announced that they will report Q3, 2025 results on Jan 15, 2025 Reported Earnings • Oct 18
Second quarter 2025 earnings released: EPS: ₹2.71 (vs ₹3.12 in 2Q 2024) Second quarter 2025 results: EPS: ₹2.71 (down from ₹3.12 in 2Q 2024). Revenue: ₹3.01b (up 14% from 2Q 2024). Net income: ₹167.4m (down 13% from 2Q 2024). Profit margin: 5.6% (down from 7.3% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. 공시 • Aug 27
Krishana Phoschem Limited Recommends Dividend for the Financial Year 2023-24 Krishana Phoschem Limited announced that at the AGM to be held on September 20, 2024, the approval of the members of the company be and is hereby granted for the payment of dividend INR 0.50 per share (i.e. 5%) on the fully paid up equity shares of INR 10/- each of the company for the Year 2023-24. 공시 • Aug 20
Krishana Phoschem Limited, Annual General Meeting, Sep 20, 2024 Krishana Phoschem Limited, Annual General Meeting, Sep 20, 2024, at 12:30 Indian Standard Time. Reported Earnings • Jul 30
First quarter 2025 earnings released: EPS: ₹2.65 (vs ₹1.92 in 1Q 2024) First quarter 2025 results: EPS: ₹2.65 (up from ₹1.92 in 1Q 2024). Revenue: ₹2.82b (up 70% from 1Q 2024). Net income: ₹164.1m (up 38% from 1Q 2024). Profit margin: 5.8% (down from 7.2% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 59% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Jun 26
MD & Director recently sold ₹59k worth of stock On the 20th of June, Praveen Ostwal sold around 200 shares on-market at roughly ₹296 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Praveen has been a net buyer over the last 12 months, purchasing a net total of ₹22m worth of shares. Recent Insider Transactions • Jun 04
MD & Director recently bought ₹2.0m worth of stock On the 30th of May, Praveen Ostwal bought around 8k shares on-market at roughly ₹249 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Praveen has been a buyer over the last 12 months, purchasing a net total of ₹22m worth in shares. Reported Earnings • May 14
Full year 2024 earnings released: EPS: ₹6.54 (vs ₹4.40 in FY 2023) Full year 2024 results: EPS: ₹6.54 (up from ₹4.40 in FY 2023). Revenue: ₹9.25b (up 187% from FY 2023). Net income: ₹404.4m (up 51% from FY 2023). Profit margin: 4.4% (down from 8.3% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 75% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 13
Third quarter 2024 earnings released: EPS: ₹0.60 (vs ₹0.75 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.60 (down from ₹0.75 in 3Q 2023). Revenue: ₹2.31b (up 396% from 3Q 2023). Net income: ₹37.0m (down 20% from 3Q 2023). Profit margin: 1.6% (down from 10.0% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 84% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Dec 07
Non-Executive Chairman recently bought ₹2.0m worth of stock On the 4th of December, Mahendra Ostwal bought around 9k shares on-market at roughly ₹234 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Mahendra's only on-market trade for the last 12 months. New Risk • Nov 17
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.8% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (47% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (6.8% net profit margin). Shareholders have been diluted in the past year (4.3% increase in shares outstanding). Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment deteriorates as stock falls 49% After last week's 49% share price decline to ₹258, the stock trades at a trailing P/E ratio of 24.5x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 296% over the past three years. Valuation Update With 7 Day Price Move • Sep 25
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹494, the stock trades at a trailing P/E ratio of 47x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 764% over the past three years. Upcoming Dividend • Sep 14
Upcoming dividend of ₹0.50 per share at 0.1% yield Eligible shareholders must have bought the stock before 21 September 2023. Payment date: 28 October 2023. Payout ratio is a comfortable 5.7% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.8%). 공시 • Aug 31
Krishana Phoschem Limited, Annual General Meeting, Sep 28, 2023 Krishana Phoschem Limited, Annual General Meeting, Sep 28, 2023, at 11:00 Indian Standard Time. Agenda: To consider and approve the audited financial statement of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors and Auditors thereon; to consider and to declare dividend on equity shares for the Financial Year 2022-23; to consider and approve the appointment of Director in place of Mr. Mahendra Kumar Ostwal who retires by rotation and being eligible, offers himself for re-appointment and in this regard; and to consider other matters. Reported Earnings • Aug 12
First quarter 2024 earnings released: EPS: ₹3.84 (vs ₹2.06 in 1Q 2023) First quarter 2024 results: EPS: ₹3.84 (up from ₹2.06 in 1Q 2023). Revenue: ₹1.66b (up 151% from 1Q 2023). Net income: ₹118.8m (up 95% from 1Q 2023). Profit margin: 7.1% (down from 9.2% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 105% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Jun 05
Insider recently bought ₹1.4m worth of stock On the 30th of May, Navin Jain bought around 3k shares on-market at roughly ₹456 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.4m. Insiders have collectively bought ₹4.7m more in shares than they have sold in the last 12 months. Recent Insider Transactions • May 08
MD & Director recently bought ₹680k worth of stock On the 4th of May, Praveen Ostwal bought around 1k shares on-market at roughly ₹474 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Praveen's only on-market trade for the last 12 months. Reported Earnings • Apr 22
Full year 2023 earnings released: EPS: ₹8.80 (vs ₹10.50 in FY 2022) Full year 2023 results: EPS: ₹8.80 (down from ₹10.50 in FY 2022). Revenue: ₹3.26b (up 2.0% from FY 2022). Net income: ₹267.4m (down 9.3% from FY 2022). Profit margin: 8.2% (down from 9.2% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 114% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jan 28
Third quarter 2023 earnings released: EPS: ₹1.50 (vs ₹2.95 in 3Q 2022) Third quarter 2023 results: EPS: ₹1.50 (down from ₹2.95 in 3Q 2022). Revenue: ₹470.6m (down 56% from 3Q 2022). Net income: ₹46.4m (down 41% from 3Q 2022). Profit margin: 9.9% (up from 7.4% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 101% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improved over the past week After last week's 15% share price gain to ₹420, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 678% over the past three years. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 3 highly experienced directors. Independent Director Gopal Inani was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 06
Second quarter 2023 earnings released: EPS: ₹3.25 (vs ₹1.60 in 2Q 2022) Second quarter 2023 results: EPS: ₹3.25 (up from ₹1.60 in 2Q 2022). Revenue: ₹650.1m (down 17% from 2Q 2022). Net income: ₹97.7m (up 128% from 2Q 2022). Profit margin: 15% (up from 5.5% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 91% per year, which means it is tracking significantly ahead of earnings growth. 공시 • Aug 25
Krishana Phoschem Limited, Annual General Meeting, Sep 28, 2022 Krishana Phoschem Limited, Annual General Meeting, Sep 28, 2022, at 15:30 Indian Standard Time. Location: 5-0-20, Basement R.c. vyas colony Bhilwara India Agenda: To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2022 and the reports of the Board of Directors and Auditors thereon; to declare dividend on equity shares for the Financial Year 2021-22; to appoint a Director in place of Mr. Praveen Ostwal (DIN 00412207), who retires by rotation and being eligible, offers himself for re-appointment; to appoint new statutory Auditors namely M/s Ashok Kanther & Associates, Chartered Accountants in place of outgoing statutory auditors namely M/S Rajneesh Kanther & Associates, Chartered Accountants whose five-year term expires with the conclusion of ensuing 18th AGM of the company; to approve and ratify the authority of Board of directors in fixing remuneration of the Cost Auditor(s) for the financial year ending 31st March 2023; and to consider other matters. Valuation Update With 7 Day Price Move • Aug 01
Investor sentiment improved over the past week After last week's 19% share price gain to ₹310, the stock trades at a trailing P/E ratio of 31.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 533% over the past three years. Reported Earnings • Jul 27
First quarter 2023 earnings released: EPS: ₹2.06 (vs ₹2.44 in 1Q 2022) First quarter 2023 results: EPS: ₹2.06 (down from ₹2.44 in 1Q 2022). Revenue: ₹661.7m (up 25% from 1Q 2022). Net income: ₹61.0m (down 6.0% from 1Q 2022). Profit margin: 9.2% (down from 12% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 26
Full year 2022 earnings released: EPS: ₹10.50 (vs ₹7.83 in FY 2021) Full year 2022 results: EPS: ₹10.50 (up from ₹7.83 in FY 2021). Revenue: ₹3.21b (up 70% from FY 2021). Net income: ₹294.6m (up 50% from FY 2021). Profit margin: 9.2% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 91% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. Non-Executive Non Independent Director Pankaj Ostwal was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. Non-Executive Non Independent Director Pankaj Ostwal was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improved over the past week After last week's 18% share price gain to ₹249, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 342% over the past three years. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improved over the past week After last week's 19% share price gain to ₹212, the stock trades at a trailing P/E ratio of 26.7x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 280% over the past three years. Reported Earnings • Feb 04
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹2.95 (up from ₹2.53 in 3Q 2021). Revenue: ₹1.07b (up 141% from 3Q 2021). Net income: ₹78.9m (up 25% from 3Q 2021). Profit margin: 7.4% (down from 14% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment improved over the past week After last week's 17% share price gain to ₹162, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 303% over the past three years. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment improved over the past week After last week's 18% share price gain to ₹138, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 279% over the past three years. Reported Earnings • Jul 23
First quarter 2022 earnings released: EPS ₹2.44 (vs ₹1.16 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹531.9m (up 30% from 1Q 2021). Net income: ₹64.9m (up 125% from 1Q 2021). Profit margin: 12% (up from 7.1% in 1Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • Jun 18
Full year 2021 earnings released: EPS ₹7.83 (vs ₹5.53 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹1.91b (up 17% from FY 2020). Net income: ₹195.8m (up 42% from FY 2020). Profit margin: 10% (up from 8.5% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improved over the past week After last week's 28% share price gain to ₹111, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 215% over the past three years. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improved over the past week After last week's 19% share price gain to ₹88.70, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 178% over the past three years. Is New 90 Day High Low • Feb 23
New 90-day low: ₹66.95 The company is down 13% from its price of ₹77.20 on 25 November 2020. The Indian market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Reported Earnings • Feb 04
Third quarter 2021 earnings released: EPS ₹2.53 (vs ₹2.40 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹446.2m (down 3.8% from 3Q 2020). Net income: ₹63.1m (up 5.7% from 3Q 2020). Profit margin: 14% (up from 13% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 30% per year. Is New 90 Day High Low • Nov 20
New 90-day high: ₹76.70 The company is up 33% from its price of ₹57.50 on 21 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. Is New 90 Day High Low • Nov 02
New 90-day high: ₹66.50 The company is up 40% from its price of ₹47.55 on 03 August 2020. The Indian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Oct 10
New 90-day high: ₹61.95 The company is up 38% from its price of ₹45.00 on 10 July 2020. The Indian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. 공시 • Jul 17
Krishana Phoschem Limited to Report Q4, 2020 Results on Jul 13, 2020 Krishana Phoschem Limited announced that they will report Q4, 2020 results on Jul 13, 2020 
